Pembrolizumab treatment for Merkel cell carcinoma
Fred Hutch selected Dr. Paul Nghiem’s article published in JCO “Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.” to be covered in the March 2019 issue of Science Spotlight, a monthly online publication highlighting scientific work performed by Fred Hutch investigators.